reports
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Result...
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025 The Company will Host a Conference Call and Webcast on May 8, 2025, at 8:30 AM ET CORAL GABLES, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its first quarter 2025 financial results after the market close on Wednesday,...
Appian to Announce First Quarter 2025 Financial Results on May 8, 2025
Appian to Announce First Quarter 2025 Financial Results on May 8, 2025 MCLEAN, Va., April 14, 2025 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced that it will release financial results for the first quarter ended March 31, 2025 before the U.S. financial markets open on Thursday, May 8, 2025. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this . Once registered, participants can join the call, using the...
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMR...
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today reported that its sub-licensee in Canada, Kye Pharmaceuticals, Inc. (Kye), has announced that Health Canada has accepted the Ne...
Atlassian Achieves FedRAMP(R) Moderate Authorization for Atlassian Gov...
TEAM Anywhere/SAN FRANCISCO--(BUSINESS WIRE)-- Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced that Atlassian Government Cloud has received Federal Risk and Authorization Management Program (FedRAMP) authorization at the Moderate level. FedRAMP is a U.S. government program that promotes the adoption of cloud technologies across the federal government by providing a standardized approach to validating security and risk controls for cloud-based products and services. With this authorization, U.S. federal, state, and local...
- Jonathan Moreland
THFF FIRST FINANCIAL CORP. (INDIANA)
ORRF ORRSTOWN FINANCIAL SERVICES INC.
MPC MARATHON PETROLEUM CORPORATION
MGPI MGP INGREDIENTS INC.
DLY LYONDELLBASELL INDUSTRIES NV
FFIN FIRST FINANCIAL BANKSHARES INC
CIM CHIMERA INVESTMENT CORPORATION
CE CELANESE CORPORATION
TREE LENDINGTREE INC.
BWFG BANKWELL FINANCIAL GROUP
SNBR SLEEP NUMBER CORPORATION
TCPC BLACKROCK TCP CAPITAL CORP.
NFE NEW FORTRESS ENERGY
ZYME ZYMEWORKS INC.
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
UAN CVR PARTNERS LP
CMTG CLAROS MORTGAGE TRUST
ECAT INC.
EBC BLACKROCK ESG CAP ALLOCATION TR
MEGI EASTERN BANKSHARES INC
NE MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SMRT NOBLE CORP (NEW)
SRBK SMARTRENT INC
NBBK SR BANCORP INC
BHRB NB BANCORP INC.
MXF BURKE HERBERT FINANCIAL SERVICES CORP
EVM THE MEXICO FUND
VG INC.
EATON VANCE INSD CALIF MUN BD FD
VENTURE GLOBAL INC.
Catalyst Pharmaceuticals Inc: 2 directors
Two Directors at Catalyst Pharmaceuticals Inc sold after exercising options/sold 93,398 shares at between 22.890USD and 22.976USD. The significance rating of the trade was 91/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trad...
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Gl...
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference CORAL GABLES, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming Barclays 27th Annual Global Hea...
- Jonathan Moreland
WWW WOLVERINE WORLD WIDE INC.
SM SM ENERGY COMPANY
SIGI SELECTIVE INSURANCE GROUP INC.
PDFS PDF SOLUTIONS INC.
PAHC PHIBRO ANIMAL HEALTH CORPORATION CLASS A
OSUR ORASURE TECHNOLOGIES INC.
OPK OPKO HEALTH INC.
MTDR MATADOR RESOURCES COMPANY
ITCI INTRA-CELLULAR THERAPIES INC.
HII HUNTINGTON INGALLS INDUSTRIES INC.
FRPT FRESHPET INC
FFIN FIRST FINANCIAL BANKSHARES INC
DGII DIGI INTERNATIONAL INC.
CPS COOPER-STANDARD HOLDINGS INC.
CLRO CLEARONE
CINF CINCINNATI FINANCIAL CORPORATION
AKAM AKAMAI TECHNOLOGIES INC.
AFG AMERICAN FINANCIAL GROUP INC.
DGICA DONEGAL GROUP INC. CL A
CECE CECO ENVIRONMENTAL CORP.
OESX ORION ENERGY SYSTEMS INC.
NHC NATIONAL HEALTHCARE CORP.
PLBC PLUMAS BANCORP
JFR NUVEEN FLOATING RATE INCOME FUND
JELD JELD-WEN HOLDING INC.
CLF CLIFFS NATURAL RESOURCES INC.
VRNA VERONA PHARMA ADS
OCSL OAKTREE SPECIALTY LENDING CORPORATION
SNBR SLEEP NUMBER CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
QNBC QNB CORP.
PCG PG &E CORPORATION
RCUS ARCUS BIOSCIENCES
REZI RESIDEO TECHNOLOGIES
CXDO INC.
CMTV CREXENDO
PRG COMMUNITY BANCORP INC. VT
VMEO PROG HOLDINGS
ETO INC.
ECAT VIMEO INC
MAIA EATON VANCE TAX ADV GBL DIV OPPTY
PFHC BLACKROCK ESG CAP ALLOCATION TR
ETG MAIA BIOTECHNOLOGY INC
EVT PROFRAC HLDG CORP
SSII EATON VANCE TAX ADV GLB DIN INC
ADVM EATON VANCE TAX ADVANTAGED DIVID IN
ISPO SS INNOVATIONS INTERNATIONAL INC
EVM ADVERUM BIOTECHNOLOGIES INC.
INSPIRATO INCORPORATED
EATON VANCE INSD CALIF MUN BD FD
Appian To Participate in Upcoming Investor Conferences
Appian To Participate in Upcoming Investor Conferences MCLEAN, Va., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) announced today that management will be presenting and hosting meetings with institutional investors at the following upcoming conferences: Morgan Stanley Technology, Media and Telecom Conference in San FranciscoTuesday, March 4, 2025A fireside chat is scheduled for 3:20pm PST and will be webcast live at the following link: KeyBanc Capital Markets Emerging Technology Summit in San FranciscoWednesday, March 5, 20251x1 Investor Meetings Cantor Global Technology Con...
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2...
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Full Year 2024 Total Revenues of $491.7 Million, Marking Another Year of Record Growth Full Year 2024 Total Revenues Grew 23.5% YoY, Driven by Strong Commercial Performance Q4 2024 Net Product Revenue of $141.8 Million, Fueled by Sustained Organic Growth of FIRDAPSE® and Continued Market Adoption of AGAMREE® Pursuing Strategic Investments to Expand Market Presence and Accelerate Growth Full Year 2025 Total Revenues Expec...
- Jonathan Moreland
WWW WOLVERINE WORLD WIDE INC.
PDFS PDF SOLUTIONS INC.
MTDR MATADOR RESOURCES COMPANY
FFIN FIRST FINANCIAL BANKSHARES INC
DGII DIGI INTERNATIONAL INC.
CPS COOPER-STANDARD HOLDINGS INC.
CINF CINCINNATI FINANCIAL CORPORATION
OCSL OAKTREE SPECIALTY LENDING CORPORATION
SNBR SLEEP NUMBER CORPORATION
QNBC QNB CORP.
TXG 10X GENOMICS INC CLASS A
CMTV COMMUNITY BANCORP INC. VT
ECBK ECB BANCORP INC.
MAIA MAIA BIOTECHNOLOGY INC
ISPO INSPIRATO INCORPORATED
Appian Announces Fourth Quarter and Full Year 2024 Financial Results
Appian Announces Fourth Quarter and Full Year 2024 Financial Results Fourth quarter cloud subscription revenue increased 19% year-over-year to $98.9 millionFull year cloud subscription revenue increased 21% year-over year to $368.0 million MCLEAN, Va., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the fourth quarter and full year ended December 31, 2024. “In 2024, Appian demonstrated its ability to grow with increasing efficiency. We specialize in creating value with AI, by deploying it in a process. While others bring work to AI, ...
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 F...
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 The Company will Host a Conference Call and Webcast on February 27, 2025, at 8:30 AM ET CORAL GABLES, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its fourth quarter and full-year 2024 financial resu...
Williams Et Atlassian Créent Atlassian Williams Racing Dans Le Cadre D...
LONDON--(BUSINESS WIRE)-- Williams Racing et Atlassian annoncent un partenariat de long terme qui marquera le début d'une nouvelle ère pour l'équipe emblématique de Formule 1 desormais nomée : Atlassian Williams Racing. Williams, la deuxième équipe ex aequo la plus titrée de l'histoire de la F1 avec 114 victoires, 9 championnats des constructeurs et 7 championnats des pilotes, s'associe à Atlassian (NASDAQ : TEAM), l'un des principaux fournisseurs de logiciels de collaboration et de productivité, utilisées par plus de 300 000 clients dans le monde. Ce partenariat réunit deux organisations ...
Williams and Atlassian Announce Title Partnership to Form Atlassian Wi...
LONDON--(BUSINESS WIRE)-- Williams Racing and Atlassian are thrilled to announce a long-term title partnership that will usher in a new era for the iconic Formula 1 team as Atlassian Williams Racing. Williams, the joint-second most successful team in F1 history with 114 wins, 9 Constructors’ Championships and 7 Drivers’ Championships is joining forces with Atlassian (NASDAQ: TEAM), a leading provider of team collaboration and productivity software whose world-class platform serves over 300,000 customers across the globe. This partnership unites two organisations driven by teamwork: Atlassi...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
VIAV VIAVI SOLUTIONS INC
ROLL RBC BEARINGS INCORPORATED
NRIM NORTHRIM BANCORP INC.
KEYS KEYSIGHT TECHNOLOGIES INC
JBT JOHN BEAN TECHNOLOGIES CORPORATION
GLW CORNING INC
EMN EASTMAN CHEMICAL COMPANY
CIEN CIENA CORPORATION
CAMT CAMTEK LTD.
BMI BADGER METER INC.
BEN FRANKLIN RESOURCES INC.
TATT TAT TECHNOLOGIES LTD.
INTT INTEST CORP.
PLSE PULSE BIOSCIENCES
LCUT LIFETIME BRANDS
ISSC INNOVATIVE SOLUTIONS & SUPPORT INC.
SRTS SENSUS HEALTHCARE
FTG111 FLATEXDEGIRO AG
CVCO CAVCO INDUSTRIES INC.
ATGE ADTALEM GLOBAL EDUCATION INC.
JHG JANUS HENDERSON GROUP PLC
BKR BAKER HUGHES COMPANY CLASS A
INS INTELLIGENT SYSTEMS CORP.
AVGO BROADCOM INC.
CSPI CSP INC.
TSSI TSS INC
INMB INMUNE BIO
TARS TARSUS PHARMACEUTICALS
HIMS HIMS AND HERS HEALTH INC (A)
GTLB GITLAB INC
VERV VERVE THERAPEUTICS INC
LNSR LENSAR INC
TEAM ATLASSIAN CORPORATION
BKSY BLACKSKY TECHNOLOGY INC
BBCN39 JPMORGAN BETABUILDERS CANADA BDR
VATE INNOVATE CORP
MNPR MONOPAR THERAPEUTICS INC.
Atlassian Announces Second Quarter Fiscal Year 2025 Results
TEAM Anywhere/SAN FRANCISCO--(BUSINESS WIRE)-- Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its second quarter ended December 31, 2024. A shareholder letter was posted on Atlassian’s Work Life blog at and in the Investor Relations section of Atlassian’s website at . Second Quarter Fiscal Year 2025 Earnings Results “The Atlassian System of Work is resonating with enterprises all over the globe, as business leaders increasingly turn to the Atlassian platform to help teams across their organiza...
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 L...
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most Successful Mid-Cap Companies for the year 2025. Catalyst has ranked an impressive fifth out of 100 companies on the list. Last year Catalyst was ranked fourth in Forbes’ list of America’s Most Successful Small-Cap Companies, with this year’s ranking recognizing the comp...
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched F...
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today reported that its sub-licensee in Japan, DyDo Pharma, Inc., ("DyDo") has launched FIRDAPSE® (amifampridine) Tablets 10 mg in Japan for the indication of improving muscle weakness in patients living with Lambert-Eaton...
Appian To Announce Fourth Quarter and Full Year 2024 Financial Results...
Appian To Announce Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 MCLEAN, Va., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: APPN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024, before the U.S. financial markets open on Wednesday, February 19, 2025. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this . Once registered, p...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.